The Leeds Clinical Research Unit has performed more than 1000 Phase I clinical studies during 20+ years of operation. Our team of physicians, licensed nurses, pharmacists, and experienced project managers have established relationships with both local and internationally-recognized opinion leaders in the fields of obesity and metabolic disorders. The result for you is:
  • Early Proof-of-Principle and Proof-of-Concept data through the use of relevant biomarkers in First-in-Human studies.

  • Preliminary efficacy data regarding feeding behavior and appetite control in both laboratory and free-living settings.

  • Expert analysis and interpretation of biomarker and efficacy data.



HAL Service Profile (pdf)
HAL Fact Sheet (pdf)
Sample Data Sheet (pdf)
Summary Validation Report (pdf)